Ascendis Pharma(MX:ASND1N)
MX$4,165.550.00 (0.00%)
MX:ASND1N
Ascendis Pharma earnings date
MX$4,165.55
At close:0.00 (0.00%)
Ascendis Pharma (ASND1N) Q4 2025 Earnings Report
0 Followers
MX:ASND1N Q4 2025 EPS Results
- Actual EPS
- -MXN 11.25
- Consensus EPS
- -MXN 1.64
- Beat/Miss
- Missed by -MXN 9.61
- One Year Ago EPS
- -MXN 13.09
MX:ASND1N Q4 2025 Revenue Results
- Actual Revenue
- MXN 5.35B
- Expected Revenue
- MXN 5.02B
- Beat/Miss
- Beat by +MXN 322.89M
- YoY Revenue Growth
- +55.28%
Earnings Announcement Details
- Quarter
- Q4 2025
- Date
- 02/11/2026
- Time
- After Close
- Conference Call
- Wednesday, February 11, 2026
MX:ASND1N Upcoming Earnings
Ascendis Pharma's next earnings date is estimated for February 17, 2027, based on past reporting schedules.
Q4 2025 Earnings Call Audio
MX:ASND1N Q4 2025 Earnings Call
0:00 / 0:00
Q4 2025 Earnings Slide Deck
No slide deck is available for this earnings event.
Q4 2025 Earnings Call Summary
No earnings call summary is available for this earnings event.
MX:ASND1N Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 17, 2027 | 2026 (Q4) | 33.13- | -11.25 | ― | ― |
| Nov 12, 2026 | 2026 (Q3) | 16.2622.09 | -20.45 | 208.00% (+42.54) | |
| Aug 13, 2026 | 2026 (Q2) | 30.6257.88 | -16.77 | 445.12% (+74.65) | |
| May 07, 2026 | 2026 (Q1) | ―199.41 | -32.31 | 717.09% (+231.72) | |
| Feb 11, 2026 | 2025 (Q4) | -1.64-11.25 | -13.09 | 14.06% (+1.84) | |
| Nov 12, 2025 | 2025 (Q3) | -4.99-20.45 | -35.18 | 41.86% (+14.73) | |
| Aug 07, 2025 | 2025 (Q2) | -26.30-16.77 | -39.06 | 57.07% (+22.29) | |
| May 01, 2025 | 2025 (Q1) | -30.00-32.31 | -47.04 | 31.30% (+14.73) | |
| Feb 12, 2025 | 2024 (Q4) | -20.12-13.09 | -31.5 | 58.44% (+18.41) | |
| Nov 14, 2024 | 2024 (Q3) | -32.01-35.18 | -55.02 | 36.06% (+19.84) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed

